WHAT WE INVEST IN

High-potential private European medical companies

Aescap Venture typically invests in private European medical companies working on the diagnosis or treatment of human diseases.

Companies are judged on the following criteria: key personnel, uniqueness/patents, product/market combinations, time-to-market, and envisaged exit opportunity.

We invest in companies active in the most promising segments in the medical industry. Companies using technologies that are sufficiently mature to yield realistic product-opportunities as well as cashflow from licensing deals.